Kuros Biosciences

Kuros Biosciences company information, Employees & Contact Information

OUR PURPOSE Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies. OUR CREDENTIALS Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team. To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing. • Level 1 evidence published in Spine • 20 well-controlled Level I – IV clinical trials initiated or completed to date • >320 cumulative scientific papers, decades of research advancing bone graft innovation • >25 orthobiologic patents secured • >20 commercial markets serving spine, extremities, trauma and oncology • 12 U.S. FDA clearances granted to date, 12 expanding MagnetOs indications CONTACT KUROS TO FIND OUT MORE >>>>

Company Details

Employees
162
Address
Wagistrasse 25, Schlieren,zurich 8952,switzerland
Phone
41 44 200 56 00
Email
in****@****uros.ch
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Schlieren, Zurich
Looking for a particular Kuros Biosciences employee's phone or email?

Kuros Biosciences Questions

News

Kuros Biosciences Expands into Extremities Markets - Ortho Spine News

Kuros Biosciences Expands into Extremities Markets Ortho Spine News

Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich - Ortho Spine News

Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich Ortho Spine News

Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025 - The Manila Times

Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025 The Manila Times

Next Generation Spine Companies and 2021 Outlook - Orthopedics This Week

Next Generation Spine Companies and 2021 Outlook Orthopedics This Week

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft - boerse.de

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft boerse.de

Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division - Ortho Spine News

Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division Ortho Spine News

Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance - Ortho Spine News

Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance Ortho Spine News

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA - Ortho Spine News

Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA Ortho Spine News

Kuros Biosciences Reports Continued Increase in MagnetOs U.S. Sales - Ortho Spine News

Kuros Biosciences Reports Continued Increase in MagnetOs U.S. Sales Ortho Spine News

Top Kuros Biosciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant